Nothing Special   »   [go: up one dir, main page]

Spaet et al., 1955 - Google Patents

Inactivation of thromboplastin in human blood

Spaet et al., 1955

View PDF
Document ID
4480502408400106077
Author
Spaet T
Garner E
et al.
Publication year
Publication venue
The Journal of Clinical Investigation

External Links

Snippet

RESULTS Preliminary studieswere undertaken to deter-mine whether the loss of thromboplastic activity in the thromboplastin generation test was due to instability ofthe thromboplastin itself or whether it resulted from the inactivating effect of some plasma …
Continue reading at www.jci.org (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/814—Enzyme separation or purification
    • Y10S435/815—Enzyme separation or purification by sorption
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)

Similar Documents

Publication Publication Date Title
Ratnoff et al. The activation of Christmas factor (factor IX) by activated plasma thromboplastin antecedent (activated factor XI)
Teitel et al. Protection of factor Xa from neutralization by the heparin-antithrombin complex.
Osterud et al. Factor V activity of platelets: evidence for an activated factor V molecule and for a platelet activator
BRECKENRIDGE et al. Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: with notes on an assay for antihemophilic factor
Seegers et al. Neutralization of autoprothrombin C activity with antithrombin
Goodnight Jr et al. Factor VII antibody-neutralizing material in hereditary and acquired factor VII deficiency
Schwartz et al. Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells
Feinstein Acquired inhibitors of factor V
Saito et al. Partial purification of plasma thromboplastin antecedent (factor XI) and its activation by trypsin
Fantl et al. Fibrinolysis following electrically induced convulsions.
Lanchantin et al. Identification of a thromboplastin inhibitor in serum and in plasma
Oesterud et al. Activation of the coagulation factor VII by tissue thromboplastin and calcium
Spaet et al. Inactivation of thromboplastin in human blood
Thompson et al. Removal of heparin and protamine from plasma
Taylor et al. Studies in blood coagulation: The coagulation properties of certain globulin fractions of normal human plasma in vitro
Ratnoff et al. Immunologic evidence that the properties of human antihemophilic factor (factor VIII) are attributes of a single molecular species
Prentice et al. Experiments on the Nature of the Prothrombin‐Converting Principle: Alteration of Proaccelerin Thrombin
Streuli On the purification and conversion of human prothrombin
Pascuzzi et al. Thromboplastin generation accelerator, a newly recognized component of the blood coagulation mechanism present in excess in certain thrombotic states
Wessler et al. On the antithrombotic action of heparin
Kondo et al. Cold Activation of Complement: I. Presence of Coagulation-Related Activator
Handley et al. A circulating anticoagulant specific for factor V
DOERR et al. New evidence for intrinsic blood coagulation in chickens
US3228841A (en) Diagnostic reagent composition for determining blood coagulation factors and method of use
Lechner Factor IX-inhibitors